2022
DOI: 10.3390/bios12020119
|View full text |Cite
|
Sign up to set email alerts
|

Haemoprocessor: A Portable Platform Using Rapid Acoustically Driven Plasma Separation Validated by Infrared Spectroscopy for Point-of-Care Diagnostics

Abstract: The identification of biomarkers from blood plasma is at the heart of many diagnostic tests. These tests often need to be conducted frequently and quickly, but the logistics of sample collection and processing not only delays the test result, but also puts a strain on the healthcare system due to the sheer volume of tests that need to be performed. The advent of microfluidics has made the processing of samples quick and reliable, with little or no skill required on the user’s part. However, while several micro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 49 publications
(55 reference statements)
0
4
0
Order By: Relevance
“…Additional studies are also needed to evaluate the high-throughput biophotonic platform and scalability issues [ 41 , 42 ] in the context of diabetes. Although the macroscale ATR-FTIR can be used in biomedical settings for the diabetes population, the development of lab-on-chip ATR-FTIR devices can be applied in point-of-care (PoC) diagnostics and vastly increase the scalability of biophotonic analysis [ 43 , 44 ], especially for diabetes condition [ 44 ]. A lab-on-chip ATR-FTIR device was proposed integrating a microfluidic approach with a pseudo-continuous flow FTIR system for glucose detection [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additional studies are also needed to evaluate the high-throughput biophotonic platform and scalability issues [ 41 , 42 ] in the context of diabetes. Although the macroscale ATR-FTIR can be used in biomedical settings for the diabetes population, the development of lab-on-chip ATR-FTIR devices can be applied in point-of-care (PoC) diagnostics and vastly increase the scalability of biophotonic analysis [ 43 , 44 ], especially for diabetes condition [ 44 ]. A lab-on-chip ATR-FTIR device was proposed integrating a microfluidic approach with a pseudo-continuous flow FTIR system for glucose detection [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Another recently developed technology is a portable haemoprocessor combined with ATR-FTIR. It was efficiently tested and can be applied in a low-volume of biofluids [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…FTIR microspectroscopy has been used in a wide variety of biological applications, including chemical mapping of changes to blood cells such as malaria-infected RBCs, hematological diseases and blood diagnostics. 10–14 The precision and versatility of FTIR-microspectroscopy is further enhanced when coupled with a synchrotron radiation energy source that significantly intensifies the beamline, facilitating ‘live-cell’ analyses, i.e. cells suspended in physiological medium.…”
Section: Introductionmentioning
confidence: 99%
“…Vibrational spectroscopy has proven to be an excellent and effective analytical tool for detecting and characterizing biological materials because it provides functional details on biochemical composition and molecular dynamics [16][17][18][19][20][21]. In particular, infrared spectroscopy has become an accepted tool for biomedical applications with many proofof-principle studies showing high specificity and sensitivity for disease detection and classification [18,20,[22][23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%